Neuronetics, Inc.
15.22%
10,588,988
1227636
Aug 2, 2026
Aug 4, 2026, 08:00 AM
Reporting Persons (1)
| Name | Type | % of Class | Aggregate | Sole Voting | Shared Voting |
|---|---|---|---|---|---|
| Chernett Jorey | Individual | 15.22% | 10,588,988 | 10,588,988 | 0 |
Disclosure Items (6)
Common Stock, $0.01 par value
Neuronetics, Inc.
3222 PHOENIXVILLE PIKE, MALVERN, PA, 19355
Item 3 is hereby amended and restated as follows: The 10,588,988 Shares held by Mr. Chernett were purchased with personal funds for an aggregate purchase price of approximately $20,682,236.
Item 5(a) is hereby amended and restated as follows: The aggregate percentage of Shares beneficially owned by the Reporting Person is based upon 69,587,840 Shares outstanding as of May 1, 2026, as disclosed in the Issuer's Quarterly Report on Form 10-Q, filed with the U.S. Securities and Exchange Commission (the "SEC") on May 5, 2026. As of the close of business on the date hereof, the Reporting Person beneficially owned 10,588,988 Shares. Percentage: Approximately 15.22%
Item 5(b) is hereby amended and restated as follows: 1. Sole power to vote or direct vote: 10,588,988 2. Shared power to vote or direct vote: 0 3. Sole power to dispose or direct the disposition: 10,588,988 4. Shared power to dispose or direct the disposition: 0
Item 5(c) is hereby amended and restated as follows: The transactions in the Shares by the Reporting Person since the filing of Amendment No. 2 to the Schedule 13D are set forth in more detail in Exhibit 1 attached hereto.
Item 6 is hereby amended to add the following: On August 3, 2026, the Reporting Person and the Issuer announced that they had reached a constructive framework for alignment between the Reporting Person and the Board (the "Understanding"). Pursuant to the Understanding, the Reporting Person will have an opportunity to recommend a newly appointed member of the Board, subject to customary Board approvals and governance processes. The foregoing description of the Understanding does not purport to be complete and is qualified in its entirety by reference to the full description of the Understanding contained in the press release published by the Issuer on August 3, 2026, a copy of which is attached as Exhibit 99.1 hereto and which is incorporated by reference herein.
Item 7 is hereby amended to add the following exhibits: Exhibit 1 - Transactions in the Securities Exhibit 99.1 - Press Release dated August 3, 2026